252 related articles for article (PubMed ID: 17616711)
1. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
Adachi S; Nagao T; Ingolfsson HI; Maxfield FR; Andersen OS; Kopelovich L; Weinstein IB
Cancer Res; 2007 Jul; 67(13):6493-501. PubMed ID: 17616711
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.
Zhu W; Li MC; Wang FR; Mackenzie GG; Oteiza PI
Biochem Pharmacol; 2020 May; 175():113923. PubMed ID: 32217102
[TBL] [Abstract][Full Text] [Related]
4. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
[TBL] [Abstract][Full Text] [Related]
5. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
Shimizu M; Shirakami Y; Moriwaki H
Int J Mol Sci; 2008 Jun; 9(6):1034-1049. PubMed ID: 19325845
[TBL] [Abstract][Full Text] [Related]
6. The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells.
Duhon D; Bigelow RL; Coleman DT; Steffan JJ; Yu C; Langston W; Kevil CG; Cardelli JA
Mol Carcinog; 2010 Aug; 49(8):739-49. PubMed ID: 20623641
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells.
Adachi S; Shimizu M; Shirakami Y; Yamauchi J; Natsume H; Matsushima-Nishiwaki R; To S; Weinstein IB; Moriwaki H; Kozawa O
Carcinogenesis; 2009 Sep; 30(9):1544-52. PubMed ID: 19578043
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway.
Ma YC; Li C; Gao F; Xu Y; Jiang ZB; Liu JX; Jin LY
Oncol Rep; 2014 Mar; 31(3):1343-9. PubMed ID: 24366444
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells.
Adachi S; Nagao T; To S; Joe AK; Shimizu M; Matsushima-Nishiwaki R; Kozawa O; Moriwaki H; Maxfield FR; Weinstein IB
Carcinogenesis; 2008 Oct; 29(10):1986-93. PubMed ID: 18586691
[TBL] [Abstract][Full Text] [Related]
11. EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
Shimizu M; Deguchi A; Joe AK; Mckoy JF; Moriwaki H; Weinstein IB
J Exp Ther Oncol; 2005; 5(1):69-78. PubMed ID: 16416603
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
14. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
Bigelow RL; Cardelli JA
Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
[TBL] [Abstract][Full Text] [Related]
15. Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT.
Annaba F; Kumar P; Dudeja AK; Saksena S; Gill RK; Alrefai WA
Am J Physiol Gastrointest Liver Physiol; 2010 Mar; 298(3):G467-73. PubMed ID: 20056894
[TBL] [Abstract][Full Text] [Related]
16. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts.
Patra SK; Rizzi F; Silva A; Rugina DO; Bettuzzi S
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():217-35. PubMed ID: 19261982
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
[TBL] [Abstract][Full Text] [Related]
18. The phyto-chemical (-)-epigallocatechin gallate suppresses gene expression of epidermal growth factor receptor in rat hepatic stellate cells in vitro by reducing the activity of Egr-1.
Fu Y; Chen A
Biochem Pharmacol; 2006 Jul; 72(2):227-38. PubMed ID: 16750517
[TBL] [Abstract][Full Text] [Related]
19. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.
Masuda M; Suzui M; Weinstein IB
Clin Cancer Res; 2001 Dec; 7(12):4220-9. PubMed ID: 11751523
[TBL] [Abstract][Full Text] [Related]
20. The anti-cancer effects of (-)-epigallocatechin-3-gallate on the signaling pathways associated with membrane receptors in MCF-7 cells.
Hsu YC; Liou YM
J Cell Physiol; 2011 Oct; 226(10):2721-30. PubMed ID: 21792929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
